Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol.

MLA

Mayor, Alfredo, et al. “Prospective Surveillance Study to Detect Antimalarial Drug Resistance, Gene Deletions of Diagnostic Relevance and Genetic Diversity of Plasmodium Falciparum in Mozambique: Protocol.” BMJ Open, vol. 12, no. 7, July 2022, p. e063456. EBSCOhost, https://doi.org/10.1136/bmjopen-2022-063456.

APA

Mayor, A., da Silva, C., Rovira-Vallbona, E., Roca-Feltrer, A., Bonnington, C., Wharton-Smith, A., Greenhouse, B., Bever, C., Chidimatembue, A., Guinovart, C., Proctor, J. L., Rodrigues, M., Canana, N., Arnaldo, P., Boene, S., Aide, P., Enosse, S., Saute, F., & Candrinho, B. (2022). Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol. BMJ Open, 12(7), e063456. https://doi.org/10.1136/bmjopen-2022-063456

Chicago

Mayor, Alfredo, Clemente da Silva, Eduard Rovira-Vallbona, Arantxa Roca-Feltrer, Craig Bonnington, Alexandra Wharton-Smith, Bryan Greenhouse, et al. 2022. “Prospective Surveillance Study to Detect Antimalarial Drug Resistance, Gene Deletions of Diagnostic Relevance and Genetic Diversity of Plasmodium Falciparum in Mozambique: Protocol.” BMJ Open 12 (7): e063456. doi:10.1136/bmjopen-2022-063456.